| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 03/19/2008 | EP1458380B1 Cis-2,4,5- triphenyl-imidazolines and their use in the treatment of tumors |
| 03/19/2008 | EP1442024B1 AMINOBENZAMIDE DERIVATIVES AS GLYCOGEN SYNTHASE KINASE 3$g(b) INHIBITORS |
| 03/19/2008 | EP1432715B1 Pyrimidine derivatives |
| 03/19/2008 | EP1423103A4 Compositions and methods for modulation of darpp-32 phosphorylation |
| 03/19/2008 | EP1362031B1 Pharmaceutically active piperidine derivatives |
| 03/19/2008 | EP1353668B1 Processes for the preparation of pharmaceutical preparations containing epothilone analogues for the treatment of cancer |
| 03/19/2008 | EP1306431B1 Tumor antigen |
| 03/19/2008 | EP1303496B9 Pyrimidine derivatives |
| 03/19/2008 | EP1149091B1 4-(heterocyclylsulfonamido)-5-methoxy-6-(2-methoxyphenoxy)-2-phenyl- or pyridylpyrimidines as endothelin receptor antagonists |
| 03/19/2008 | EP1042293B1 Substituted pyridine and pyridazine compounds and their pharmaceutical use |
| 03/19/2008 | EP1012240B1 Cancer immunotherapy with semi-allogeneic cells |
| 03/19/2008 | CN101146909A Antigen binding molecules directed to MCSP and having increased Fc receptor binding affinity and effector function |
| 03/19/2008 | CN101146825A A molecule and chimeric molecules thereof |
| 03/19/2008 | CN101146806A Pyrazole derivatives for the inhibition of CDK and GSK |
| 03/19/2008 | CN101146803A Pyrrolidine inhibitors of IAP |
| 03/19/2008 | CN101146796A 3-(indazol-5-yl)-(1,2,4)triazine derivatives and related compounds as protein kinase inhibitors for the treatment of cancer |
| 03/19/2008 | CN101146795A Pyrazole derivatives for the inhibition of CDK and GSK |
| 03/19/2008 | CN101146794A Pyrazole derivatives for the inhibition of CDK and GSK |
| 03/19/2008 | CN101146791A 4-(2,6-dichlorobenzoylamino)-1H-pyrazole-3-carboxylic acid piperidin-4-ylamid acid addition salts as kinase inhibitors |
| 03/19/2008 | CN101146789A Chemical compounds |
| 03/19/2008 | CN101146780A New 3-aryl-1,2-benzisoxazole compounds are heat shock protein 90 inhibitors, useful to treat solid or liquid cancer, preferably cancers resistant to cytotoxic agents |
| 03/19/2008 | CN101146575A New class of gamma delta T cells activators and use thereof |
| 03/19/2008 | CN101146553A Anti-CTLA4 antibody and indolinone combination therapy for treatment of cancer |
| 03/19/2008 | CN101146552A Therapy of prostate cancer with CTLA4 antibodies and hormonal therapy |
| 03/19/2008 | CN101146549A Antiangiogenic agents and aldesleukin |
| 03/19/2008 | CN101146548A Methods for treating lymphomas using a combination of a chemotherapeutic agent and IL-2 and optionally an anti-CD20 antibody |
| 03/19/2008 | CN101146533A Combinations of pyrazole kinase inhibitors and further antitumor agents |
| 03/19/2008 | CN101146532A Pharmaceutical compounds |
| 03/19/2008 | CN101146531A Pharmaceutical compounds |
| 03/19/2008 | CN101144081A Nucleic acid molecule TRAIL and application in preparation of anti-tumour pharmaceutical |
| 03/19/2008 | CN101143902A Anti-HER2 single-chain antibody-cefuroxime sodium enhanced fusion protein HER2(Fv-LDM) |
| 03/19/2008 | CN101143895A Polypeptide with tumour targeting effects and preparation method thereof |
| 03/19/2008 | CN101143894A Highly effective polypeptide for inhibiting angiogenesis, physical chemistry modifying method and application thereof |
| 03/19/2008 | CN101143893A Thymus tripeptide active isomer and preparation method and medical use thereof |
| 03/19/2008 | CN101143890A New born calf brain active peptide, preparation method and application thereof in preparing anti-cancer medicament |
| 03/19/2008 | CN101143866A Chlorophyll derivatives, preparation method and application thereof in medical agricultural chemicals |
| 03/19/2008 | CN101143222A Application of p53 expression product in preparing medicine for treating tumor |
| 03/19/2008 | CN101143221A Central airway administration for systemic delivery of therapeutics |
| 03/19/2008 | CN101143209A Application of KILLER polypeptide in preparing medicine for treating tumor |
| 03/19/2008 | CN101143193A Anticancer component composition decoction and preparation method thereof |
| 03/19/2008 | CN101143191A Medicine capable of relieving side effects of mastocarinoma radiotherapy and chemotherapy |
| 03/19/2008 | CN101143178A Traditional Chinese medicine for treating late esophagus cancer |
| 03/19/2008 | CN101143170A Traditional Chinese medicine composition for treating rectum cancer |
| 03/19/2008 | CN101143167A Medicine for treating cancer and preparing method thereof |
| 03/19/2008 | CN101143157A Tyrosol and tyrosol bypass salidroside plant extraction and preparation and use thereof |
| 03/19/2008 | CN101143155A Double ginseng composition and its application |
| 03/19/2008 | CN101143151A Traditional Chinese medicinal composition for treating cancer |
| 03/19/2008 | CN101143149A Compound extracting and separating method and its application as medicine |
| 03/19/2008 | CN101143148A Application of paris saponin I and its derivatives |
| 03/19/2008 | CN101143141A Baicalein or scutellarein and doxifluridine combined |
| 03/19/2008 | CN101143134A Dexrazoxane freezing-dried powder injection and preparation method thereof |
| 03/19/2008 | CN101143130A Carmustine intravenous emulsion and its preparation method |
| 03/19/2008 | CN101143129A Methotrexate intravenous emulsion and its preparation method |
| 03/19/2008 | CN101143025A Mixed type liquid cigarette and its preparation technique and application |
| 03/19/2008 | CN100375786C Recombinant MVA capable of expressing structural HCV antigens |
| 03/19/2008 | CN100375755C Longleaf Grateloupia acuminata polysaccharide extract and its preparation and use |
| 03/19/2008 | CN100375635C Water soluble anti-cancer medicine slow-release fiber preparation and preparing method therefor |
| 03/19/2008 | CN100375627C Application of match drug Chinese goldthread and evodia fruit extracts in preparation of medicine for preventing and treating cancer |
| 03/19/2008 | CN100375622C Freeze dried powder injection of cytarabine and its preparation process |
| 03/19/2008 | CN100375621C Vinorelbine liposome micro ball injection and its preparation method |
| 03/18/2008 | US7345174 Selectively inducing terminal differentiation of neoplastic cells; antiproliferative agents; antineoplastic agents; antitumor agents; melanomes; acute leukemia, multiple myeloma; carcinomas; neuroblastoma; N-t-butoxycarbonyl- omega -methyl - alpha -aminosuberateanilide |
| 03/18/2008 | US7345172 Intercalation compound for use in the diagnosis and detection of genetic disorders; sterically demanding nucleotide intercalating compounds and methods for detecting base pair mismatches in nucleic acid sequences |
| 03/18/2008 | US7345171 Isethionate salt of a selective CKD4 inhibitor |
| 03/18/2008 | US7345156 Hepatocellular carcinoma-related genes and polypeptides, and method for detecting hepatocellular carcinomas |
| 03/18/2008 | US7345151 Antagonists specific for denatured collagen and methods of using same |
| 03/18/2008 | US7345138 Biodegradable polyphosphates for controlled release of bioactive substances |
| 03/18/2008 | US7345094 Synergistic; side effect reduction; melanomas; toxicity; 2,5-Dimethoxythiobenzoic Acid N-methylhydrazine; anticancer |
| 03/18/2008 | US7345088 Synergistic mixtures |
| 03/18/2008 | US7345068 Aromatic amino acid derivatives and medicinal compositions |
| 03/18/2008 | US7345067 peroxisome proliferator activators such as (2-methyl-4-{methyl-[4-methyl-2-(4-trifluoromethyl-phenyl)-thiazol-5-ylmethyl]-amino}-phenoxy)-acetic acid, used as lipid modulators and insulin sensitizers |
| 03/18/2008 | US7345066 Use of thiazole derivatives for preparing a medicine for protecting mitochondria |
| 03/18/2008 | US7345065 Using adrenergic receptors; side effect reduction |
| 03/18/2008 | US7345063 Amides, preparation and therapeutic use as modulators of CCR-receptor activity |
| 03/18/2008 | US7345062 Substituted acylhydroxamic acids and method of reducing TNFαlevels |
| 03/18/2008 | US7345054 Heterocyclic inhibitors of ERK2 and uses thereof |
| 03/18/2008 | US7345050 Imidazo(1,2a)pyridine or pyrazolo(2,3a)pyridine derivatives; Alzheimer's and Parkinson's Disease; nervous system, brain, and psychological disorders |
| 03/18/2008 | US7345046 Using quinazoline type compound ; antiproliferative agents |
| 03/18/2008 | US7345033 Carbamoyl-and thiocarbamoyl-phosphonates and pharmaceutical compositions comprising them |
| 03/18/2008 | US7345023 Treatment of hyperproliferative conditions of body surfaces |
| 03/18/2008 | US7344829 Methods for detecting the efficacy of anticancer treatments |
| 03/18/2008 | US7344721 Polypeptide for the treatment of cancer and a method for preparation thereof |
| 03/18/2008 | US7344715 Method for treating multiple myeloma |
| 03/18/2008 | US7344711 Administering an adenovirus defective in its VAI and VAII virus-associated RNAs |
| 03/18/2008 | CA2320430C Recombinant mistletoe lectins |
| 03/18/2008 | CA2264739C Inhibition of nuclear transcription factor nf-kb by caffeic acid phenethyl ester (cape), derivatives of cape, capsaicin (8-methyl-n-vanillyl-6-nonenamide) and resiniferatoxin |
| 03/18/2008 | CA2219659C Rapamycin derivatives |
| 03/18/2008 | CA2185043C Monoclonal antibodies recognizing tie-receptor and their use |
| 03/18/2008 | CA2181073C Tissue-specific enhancer active in prostate |
| 03/18/2008 | CA2121689C 1.alpha.,24(s)-dihydroxy vitamin d2, its formation and use |
| 03/18/2008 | CA2015060C Novel antibody delivery system for biological response modifiers |
| 03/14/2008 | CA2568354A1 Preparation of antibody or an antibody fragment-targeted immunoliposomes for systemic administration of therapeutic or diagnostic agents and uses thereof |
| 03/13/2008 | WO2008030883A2 Treatment of cancer |
| 03/13/2008 | WO2008030448A1 Phenethylamide derivatives with kinase inhibitory activity |
| 03/13/2008 | WO2008030119A1 Acyclic amine inhibitors of nucleoside phosphorylases and hydrolases |
| 03/13/2008 | WO2008030118A1 Acyclic amine inhibitors of 5'-methylthioadenosine phosphorylase and nucleosidase |
| 03/13/2008 | WO2008029912A1 Compound having benzamide skeleton and cyclooxygenase (cox-1)-selective inhibitory activity |
| 03/13/2008 | WO2008029908A1 Stable lyophilized pharmaceutical preparation comprising antibody |
| 03/13/2008 | WO2008029807A1 Novel polypeptide having cytotoxicity against cancer, method for screening for the polypeptide, and use of the polypeptide |
| 03/13/2008 | WO2008029790A1 Novel nucleic acid |
| 03/13/2008 | WO2008029619A1 Ena antisense oligonucleotide having sequence-specific action |